Previous 10 | Next 10 |
Organon Canada Declares Paid Time Off for All Employees on International Women's Day; All Employees in Canada to Focus on Their Own Health in Recognition of Growing Women's Health Inequity Canada NewsWire As the COVID-19 pandemic continues to have a disproportionate ...
As the COVID-19 pandemic continues to have a disproportionate impact on women , Organon issues a call to action for other leaders to create opportunities to focus on women’s health Organon (NYSE: OGN), a global women’s health company, is designating Int...
Organon (NYSE: OGN), will release its fourth quarter and full year 2021 financial results on February 17, 2022, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST. Interested parties may access the live call via webcast on the Organon website at ...
NEXPLANON® (ETONOGESTREL EXTENDED-RELEASE SUBDERMAL IMPLANT) NOW COVERED BY ONTARIO, BRITISH COLUMBIA AND NOVA SCOTIA'S PUBLIC FORMULARIES Canada NewsWire KIRKLAND, QC , Jan. 11, 2022 /CNW/ - Organon Canada — Organon (NYSE: OGN) — is pleased to...
Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for a citrate-free, high-concentration (100 mg/mL) formulation of SB5 (adalimumab-bw...
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 40th Annual J.P. Morgan Healthcare Virtual Conference on Monday, January 10, 2022 at 2:15 p.m. ET. Investo...
Expands women’s health pipeline with novel candidates targeting endometriosis and polycystic ovarian syndrome (PCOS) Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo Pharma, a clinical-stage ...
Organon has seen material share price weakness as of late. The selling appears to be unjustified, however, considering Organon's recent business fundamentals. Meanwhile, OGN pays a respectable dividend with a low payout ratio, and has growth catalysts in its Women's Health and Bio...
Organon fell after posting quarterly results. Shareholders are nervous about recent acquisition. Fair value introduced. For further details see: Why Buy Organon After Shares Fell Below $30
Organon & Co. (OGN) 4th Annual Evercore ISI HealthCONx Conference December 1, 2021 1:50 PM ET Company Participants Kevin Ali - CEO Matthew Walsh - CFO Conference Call Participants Umer Raffat - Evercore Eric Musonza - Evercore Presentation Umer Raffat 00:00 Hello, everyone. Thank you for ...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...